We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
-13.01%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$276M
AUM Growth
-$52.8M
Cap. Flow
+$7.73M
Cap. Flow %
2.8%
Top 10 Hldgs %
72.28%
Holding
60
New
12
Increased
22
Reduced
11
Closed
4

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$20.8M
2
ASRT
Assertio
ASRT
+$8.97M
3
META icon
Meta Platforms (Facebook)
META
+$3.05M
4
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$2.65M
5
AMZN icon
Amazon
AMZN
+$2.57M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$24.7M
2
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$4.16M
3
BWLD
Buffalo Wild Wings, Inc.
BWLD
+$2.44M
4
BIIB icon
Biogen
BIIB
+$2M
5
CMG icon
Chipotle Mexican Grill
CMG
+$1.4M

Sector Composition

Rank Sector Weight
1 Healthcare 74.36%
2 Communication Services 9.92%
3 Consumer Discretionary 5.83%
4 Financials 4.76%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGNT
26
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.64M 0.59%
106,630
-5,000
-4% -$108K
CBM
27
DELISTED
Cambrex Corporation
CBM
$1.61M 0.58%
40,573
+5,328
+15% +$249K
WING icon
28
Wingstop
WING
$3.67B
$1.49M 0.54%
+62,057
New +$1.81M
ANIP icon
29
ANI Pharmaceuticals
ANIP
$1.84B
$1.42M 0.51%
35,864
– –
SHPG
30
DELISTED
Shire pic
SHPG
$1.33M 0.48%
6,507
+65
+1% +$15.5K
LCI
31
DELISTED
Lannett Company, Inc.
LCI
$1.32M 0.48%
7,961
– –
ENDP
32
DELISTED
Endo International plc
ENDP
$914K 0.33%
13,192
-9,693
-42% -$776K
MNK
33
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$816K 0.3%
12,766
-7,890
-38% -$782K
VNDA icon
34
Vanda Pharmaceuticals
VNDA
$310M
$805K 0.29%
71,377
-27,398
-28% -$335K
AKRX
35
DELISTED
Akorn Inc
AKRX
$756K 0.27%
26,506
– –
SHAK icon
36
Shake Shack
SHAK
$2.55B
$690K 0.25%
14,548
+134
+0.9% +$7.3K
TLGT
37
DELISTED
Teligent, Inc
TLGT
$593K 0.21%
9,072
-5,791
-39% -$447K
ADMS
38
DELISTED
Adamas Pharmaceuticals
ADMS
$505K 0.18%
+30,140
New +$686K
TVTX icon
39
Travere Therapeutics
TVTX
$5.2B
$489K 0.18%
24,147
+223
+0.9% +$6.61K
STRR
40
DELISTED
Star Equity Holdings
STRR
$412K 0.15%
2,205
– –
FRSH
41
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$304K 0.11%
20,724
+195
+0.9% +$3.37K
PETS icon
42
PetMed Express
PETS
$43M
$301K 0.11%
+18,702
New +$314K
SRPT icon
43
Sarepta Therapeutics
SRPT
$1.63B
$256K 0.09%
7,974
+75
+0.9% +$2.54K
ATRS
44
DELISTED
Antares Pharma, Inc.
ATRS
$242K 0.09%
142,198
– –
PTX
45
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$212K 0.08%
6,701
-3,466
-34% -$166K
XNPT
46
DELISTED
XENOPORT, INC.
XNPT
$174K 0.06%
+50,000
New +$316K
CCLD icon
47
CareCloud
CCLD
$100M
$115K 0.04%
63,771
– –
ICPT
48
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$98K 0.04%
+591
New +$130K
GERN icon
49
Geron
GERN
$930M
$83K 0.03%
30,000
– –
CTIC
50
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$76K 0.03%
5,227
– –
1
2
3

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, JW Asset Management held 60 positions worth $276M, down 16% from $329M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

JW Asset Management's Q3 2015 filing shows 12 new, 22 increased, 11 reduced and 4 closed positions. Its largest new stake was Assertio: 5,254 shares worth $5.94M. The largest sale was Apple, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, down from 77% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • JW Asset Management's largest Q3 2015 buy was Assertio: 5,254 shares worth $5.94M.
  • JW Asset Management added most to Netflix in Q3 2015, an estimated $20.8M increase.
  • JW Asset Management's biggest Q3 2015 reduction was Taro Pharmaceutical Industries Ltd., cutting an estimated $4.16M.
  • JW Asset Management fully exited Apple in Q3 2015, selling an estimated $24.7M.
  • JW Asset Management's ten largest holdings make up 72% of its $276M portfolio in Q3 2015.
  • JW Asset Management opened 12 new positions and closed 4 in Q3 2015.
  • JW Asset Management's portfolio value fell 16% quarter-over-quarter to $276M.

Based on JW Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.